Profiel
Kensaku Akita has worked as a Director at Applizyme, Inc. and as a Manager at Yoshindo, Inc.
Actieve functies van Kensaku Akita
| Bedrijven | Functie | Begin |
|---|---|---|
Applizyme, Inc.
 Applizyme, Inc. BiotechnologyHealth Technology Applizyme, Inc. is a holding company that develops deoxygenize activity for polychlorinated biphenyls (PCBs). It develops and offers technologies designed to render harmful substances harmless by using microorganisms and enzymes derived from those microorganisms. The firm’s solutions and technologies detoxify persistent organochlorine compounds, such as PCBs, and provide joint-storage for microbes that have industrial uses. The company was founded on August 10, 2011 and is headquartered in Yonezawa, Japan. | Directeur/Bestuurslid | - |
Yoshindo, Inc.
 Yoshindo, Inc. Pharmaceuticals: MajorHealth Technology Yoshindo, Inc. is a pharmaceutical company based in Japan that specializes in producing high-quality generic drugs, essential drugs for infusion and dialysis, and conducting research and development of biopharmaceuticals. The Japanese company aims to become an indispensable player in the pharmaceutical industry in Japan. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Yoshindo, Inc.
Yoshindo, Inc. Pharmaceuticals: MajorHealth Technology Yoshindo, Inc. is a pharmaceutical company based in Japan that specializes in producing high-quality generic drugs, essential drugs for infusion and dialysis, and conducting research and development of biopharmaceuticals. The Japanese company aims to become an indispensable player in the pharmaceutical industry in Japan. | Health Technology |
Applizyme, Inc.
Applizyme, Inc. BiotechnologyHealth Technology Applizyme, Inc. is a holding company that develops deoxygenize activity for polychlorinated biphenyls (PCBs). It develops and offers technologies designed to render harmful substances harmless by using microorganisms and enzymes derived from those microorganisms. The firm’s solutions and technologies detoxify persistent organochlorine compounds, such as PCBs, and provide joint-storage for microbes that have industrial uses. The company was founded on August 10, 2011 and is headquartered in Yonezawa, Japan. | Health Technology |
